The August 2026 Editors’ Picks from AACR journals cover the impact of weight loss and omega-3 supplementation on breast cancer risk, early-onset cancer prediction, and more.
The post Editors’ Picks, August 2026: Weight Loss and Breast Cancer Biomarkers, Predicting Early-onset Cancer Cases, and More appeared first on American Association for Cancer Research (AACR).

Ovarian cancer is often diagnosed at an advanced stage, but research is reshaping how scientists understand and treat the disease. From discoveries about its origins to new FDA-approved therapies, learn how scientific advances are creating new possibilities for patients, including the first immunotherapy-based regimen for this cancer type and a first-of-its-kind selective glucocorticoid receptor antagonist.
The post How New Science is Reshaping Ovarian Cancer Treatment and Care appeared first on American Association for Cancer Research (AACR).

A variety of national and local news outlets have highlighted AACR initiatives and experts in recent weeks. Learn about the news stories covering the findings from the AACR Cancer Disparities Progress Report 2026 and AACR’s statement about the White House Office of Management and Budget’s proposal to change how federal grants are awarded and managed.
The post AACR in the News: Cancer Disparities Progress Report and OMB Statement appeared first on American Association for Cancer Research (AACR).

We highlight some of the many innovations showcased at the inaugural AACR Drug Discovery and Development (AACR D3) conference, including investigational KRAS degraders, approaches to drug p53 and MYC, and new AI tools for drug discovery.
The post AACR D3 Offered a Peek Into the Cancer Drug Pipeline, Innovative AI Tools, and More appeared first on American Association for Cancer Research (AACR).

Menopausal hormone therapy no longer has the highest-level warning label about the risk of breast cancer, opening a gray area on who would benefit most from treatment.

The summer issue of Cancer Today includes articles about integrating patient-reported outcomes into clinical research and care, advances in preventing and treating graft-versus-host disease, researchers’ efforts to better understand the mechanisms of treatment resistance, advice about divulging a cancer diagnosis when dating, and more.
The post Cancer Today’s Summer 2026 Issue: Using Patient-reported Outcomes to Address Side Effects, Preventing Graft-versus-host Disease, and More appeared first on American Association for Cancer Research (AACR).

At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President Lillian L. Siu, MD, FAACR, announced the AACR Rare Cancers Initiative. Learn more about how this new Initiative will marshal global resources and expertise to drive rare cancer research forward.
The post The AACR Rare Cancers Initiative: Uniting Researchers, Undoing Barriers, and Unleashing Progress appeared first on American Association for Cancer Research (AACR).

Cancer survivors often experience cognitive, visual or physical challenges that hinder software use. Better designs can help.

Cancer immunology expert and former AACR president Elizabeth Jaffee, MD, FAACR, discusses the latest progress in the research on pancreatic cancer vaccines and explains why cancer interception in individuals at high risk is the new frontier of the field.
The post From Treatment to Prevention: How Vaccines Are Reshaping the Fight Against Pancreatic Cancer appeared first on American Association for Cancer Research (AACR).

Exposure to wildfire smoke may increase the risk of developing several cancers, according to research presented at the AACR Annual Meeting 2026 by Shuguang Leng, MBBS, PhD, and Qizhen Wu, PhD, both of the University of New Mexico Comprehensive Cancer Center. Amid bigger U.S. wildfires, wildfire smoke’s impacts on human health are increasingly relevant.
The post Catching the Drift: How Wildfire Smoke Plumes May Increase Cancer Risk appeared first on American Association for Cancer Research (AACR).